Skip to content
  • Phone
  • Mail

INVESTOR RELATIONS    ONLINE STORE    PRESS KIT    CONTACT

ExpreS2ion Biotechnologies

ExpreS2ion Biotechnologies

We’re Here To Solve Your Biggest Protein Challenges

  • The Company
    • Our Business
    • History
    • Group Structure
    • Management Team
    • Board of Directors
    • Careers
  • Our Technology Platform
    • The ExpreS2 Platform!
    • S2 and glyco-modified cell lines
    • The ExpreS2 TR transfection reagent
    • AdaptVac’s VLP technology
    • The ExpreS2 Kit
    • ExpreS2 FAQs
    • ExpreS2 usage in malaria vaccine development
  • Project Pipeline & Partners
    • Pipeline
    • Partners
  • Services & Products
    • Custom made proteins and reagents
    • Transfection Reagents
    • Process development
    • Feasibility studies
    • Licensing
  • News & Publications
    • News
    • Research publications
    • Meet Us
  • INVESTOR RELATIONS
  • Online Store
  • Contact
0

Cart

Category: News

  • Home
  • News

Fuld fokus på terapeutisk vaccine

October 27, 2021October 27, 2021

ExpreS2ion Biotechnologies is featured in a publication by Dansk Biotek today (in Danish). Our CEO, Bent Frandsen, presents one of […]

News

Company presentation

July 1, 2021

Check out ExpreS2ion Biotechnologies in this short video. Making a difference within oncology and infectious diseases – and we are […]

News

Science Talk: Fast-tracking of a COVID-19 vaccine development

December 16, 2020December 16, 2020

Join us for this Science Talk with Drs. Ali Salanti, Max M Søgaard, and Louise Leth Hefting on development of […]

News

ExpreS2ion is mentioned in Ingeniøren

February 24, 2020February 24, 2020

Read full article here: https://ing.dk/artikel/danskere-vil-dyrke-coronavaccine-bananflueceller-232322

News

ExpreS2ion is mentioned in Nigerian Guardian

February 24, 2020February 24, 2020

Read full article here: https://guardian.ng/interview/drug-shortage-imminent-if-coronavirus-epidemic-persists/

News

ExpreS2ion’s CSO Dr. Wian de Jongh to speak at the ISBiotech 8th Spring Meeting in Norfolk, Virginia, USA – March 5-7

February 28, 2018

ExpreS2ion Biotechnologies will be presenting at the ISBiotech 8th Spring Meeting taking place on March 5-7, 2018 in Norfolk, Virginia, […]

News

Upcoming Webinar: Developing an anti-HER2 breast cancer vaccine using advantageous Drosophila S2 cell protein expression and virus-like -particle display technologies

February 27, 2018

ExpreS2ion Biotechnologies and AdaptVac will be presenting at the free webinar on March 14 at 5PM CET / 4PM GMT […]

News

Media article about ExpreS2ion in Affärstidningen Näringsliv, a journal about Life Science in Greater Copenhagen

February 15, 2018

Expres2ion Biotechnologies is mentioned in the Swedish newspaper Affärstidningen Näringsliv, in the supplement section “Time to Unite – a Greater […]

News

Media article about ExpreS2ion in MedWatch, a Danish business journal about the Life Sciences industry

February 8, 2018February 15, 2018

ExpreS2ion Biotechnologies is the topic of an article (in Danish) in the business journal MedWatch under the headline “ExpreS2ion-direktør efter […]

News

ExpreS2ion Biotechnologies Announces Research License Agreement with the University of Pennsylvania

November 8, 2017

Horsholm, Denmark, November 8, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]

News

Posts navigation

Older posts

Contact us

You are welcome to contact us by using this form or our contact information at the end of this page if you want to know more about ExpreS2ion.

    If your enquiry is investor related, please submit it here

    Subscribe to our newsletter

    ExpreS2ion regularly issues newsletters to its customers and collaboration partners. If you would like to subscribe to these please enter your details below. We handle all details conf. our privacy policy.

    If your news interest concerns our NASDAQ-regulated press releases please go to our Investor site with PRs there, or go to Cision site where it is possible to subscribe.

    Subscribe

    * indicates required

    ExpreS2ion Biotechnologies
    Agern Allé 1, DK-2970 Horsholm, Denmark
    E-mail: info(a)expres2ionbio.com
    Phone: +45 2222 1019

    Cookies help us deliver our services. By using our services, you agree to our use of cookies. Got it!
    Read more about cookies in our Privacy Policy | Terms & General Conditions | Legal Notice & Disclaimer

    Follow Us

    Website by DesignStudio.dk

    Copyright © 2022 ExpreS2ion Biotechnologies All rights reserved. Theme: Flash by ThemeGrill. Powered by WordPress
    Get a quote - PFs48/45
    [contact-form-7 404 "Not Found"]
    Referrals - PFs48/45
    Give me a call - PFs48/45
    [contact-form-7 404 "Not Found"]
    Referrals - TLR8
    Referrals - TLR7
    Referrals - Ns2B-Ns3
    Referrals - GP
    Referrals - EctoG
    Referrals - E80
    Referrals - CrystG
    Give me a call - TLR8
    [contact-form-7 404 "Not Found"]
    Give me a call - TLR7
    [contact-form-7 404 "Not Found"]
    Give me a call - Ns2B-Ns3
    [contact-form-7 404 "Not Found"]
    Give me a call - EctoG
    [contact-form-7 404 "Not Found"]
    Give me a call - E80
    [contact-form-7 404 "Not Found"]
    Give me a call - GP
    [contact-form-7 404 "Not Found"]
    Give me a call - CrystG
    [contact-form-7 404 "Not Found"]
    Get a quote - TLR8
    [contact-form-7 404 "Not Found"]
    Get a quote - TRL7
    [contact-form-7 404 "Not Found"]
    Get a quote - Ns2B-Ns3
    [contact-form-7 404 "Not Found"]
    Get a quote - CrystG
    [contact-form-7 404 "Not Found"]
    Get a quote - E80
    [contact-form-7 404 "Not Found"]
    Get a quote - EctoG
    [contact-form-7 404 "Not Found"]
    Get a quote - GP
    [contact-form-7 404 "Not Found"]
    Get a quote - Ns1
    [contact-form-7 404 "Not Found"]
    Give me a call - Ns1
    [contact-form-7 404 "Not Found"]
    Referrals - Ns1
    Referrals - Rh5
    Get a quote - Rh5
    [contact-form-7 404 "Not Found"]
    Give me a call - Rh5
    [contact-form-7 404 "Not Found"]